Bortezomib in combination with thalidomide or lenalidomide or doxorubicin regimens for the treatment of multiple myeloma: a meta-analysis of 14 randomized …

L Wang, YL Xu, XQ Zhang - Leukemia & Lymphoma, 2014 - Taylor & Francis
The aim of the study was to evaluate the clinical efficacy and safety of bortezomib-based
regimens for the treatment of multiple myeloma through meta-analysis. The literature on …
被引用次数：18 相关文章

Bortezomib in combination with thalidomide or lenalidomide or doxorubicin regimens for the treatment of multiple myeloma: a meta-analysis of 14 randomized …

L Wang, YL Xu, XQ Zhang - Leukemia & Lymphoma, 2014 - europepmc.org
Bortezomib in combination with thalidomide or lenalidomide or doxorubicin regimens for the
treatment of multiple myeloma: a meta-analysis of 14 randomized controlled trials. - Abstract …

Bortezomib in combination with thalidomide or lenalidomide or doxorubicin regimens for the treatment of multiple myeloma: a meta-analysis of 14 randomized …

L Wang, YL Xu, XQ Zhang - Leukemia & lymphoma, 2014 - pubmed.ncbi.nlm.nih.gov
The aim of the study was to evaluate the clinical efficacy and safety of bortezomib-based
regimens for the treatment of multiple myeloma through meta-analysis. The literature on …

Bortezomib in combination with thalidomide or lenalidomide or doxorubicin regimens for the treatment of multiple myeloma: a meta-analysis of 14 randomized …

L Wang, YL Xu, XQ Zhang - Leukemia & Lymphoma, 2014 - search.ebscohost.com
The aim of the study was to evaluate the clinical efficacy and safety of bortezomib-based
regimens for the treatment of multiple myeloma through meta-analysis. The literature on …